ASIA-PACIFIC HORMONE REPLACEMENT THERAPY MARKET 2021-2028

Lifesciences | Healthcare & Wellness

ASIA-PACIFIC HORMONE REPLACEMENT THERAPY MARKET 2021-2028

Market by Therapy Type, Type of Disease, Route of Administration, and Country | Forecast 2021-2028

Request Free Sample

Request Custom Report

Request Custom Report

Enquire before buying

Enquire Before Buying

The Asia-Pacific hormone replacement therapy market is estimated to display growth at 8.45% of CAGR during the forecasted years 2021-2028.


Report scope can be customized per your requirements. Request For Customization

The countries assessed in this market include:

•        India

•        China

•        Japan

•        Australia & New Zealand

•        South Korea

•        ASEAN countries

•        Rest of Asia-Pacific

In the Asia-Pacific region, the hormone replacement therapy market is anticipated to witness growth owing to several factors, such as the surge in awareness about hormonal disorders, enhancement in the healthcare sector, and rise in the geriatric population. In China, the launch of novel drugs and therapies to treat secondary hyperparathyroidism is supplementing the development of the studied market to a large extent. For instance, Novo Nordisk has expanded its business operations by introducing treatments in the areas of hemostasis management, growth hormone, and hormone replacement therapies. Hence, such steps undertaken by prominent market players are likely to boost the hormone replacement therapy market on a growth path across Asia-Pacific.

On the other hand, medical professionals favor hormone replacement therapy for estrogen, as per the Japanese Gynecologic Oncology Group’s study. Moreover, they are likely to increase the prescription rate for medicines that do not lead to the development of endometrial cancer as a result of adverse effects. Furthermore, higher emphasis on early detection is estimated to offer lucrative growth opportunities to the market over the next few years. Above all, there are guidelines set for hormone replacement therapy in the country, which is projected to positively impact the hormone replacement therapy market in Japan.

Dr Reddy’s Laboratories Ltd manufactures and distributes a variety of pharmaceuticals. Its comprehensive product line includes diagnostic kits, active pharmaceutical ingredients for drug manufacture, and biotechnology products. Among its products, Pamorelin LA is primarily used for treating locally advanced hormone-reliant prostate cancer. Incorporated in 1984, the company has its headquarters based in Hyderabad, India. 

Related Reports

ASIA PACIFIC AESTHETIC LASER MARKET 2019-2027
Lifesciences

ASIA PACIFIC AESTHETIC LASER MARKET 2019-2027

Market By Type, Application, E ..

VIEW REPORT
ASIA PACIFIC BIOCHIPS MARKET 2019-2027
Lifesciences

ASIA PACIFIC BIOCHIPS MARKET 2019-2027

Market By Type, Substrate Mate ..

VIEW REPORT
ASIA PACIFIC BIOPSY DEVICE MARKET 2019-2027
Lifesciences

ASIA PACIFIC BIOPSY DEVICE MARKET 2019-2027

Market By Device Type, Therape ..

VIEW REPORT
ASIA PACIFIC DNA VACCINES MARKET 2019-2027
Lifesciences

ASIA PACIFIC DNA VACCINES MARKET 2019-2027

Market By Type, Application, T ..

VIEW REPORT
ASIA-PACIFIC 3D CELL CULTURE MARKET 2019-2027
Lifesciences

ASIA-PACIFIC 3D CELL CULTURE MARKET 2019-2027

Market By Technology, Applicat ..

VIEW REPORT
ASIA-PACIFIC AIRWAY CLEARANCE SYSTEM MARKET 2019-2028
Lifesciences

ASIA-PACIFIC AIRWAY CLEARANCE SYSTEM MARKET 2019-2028

Market By Application, Type, E ..

VIEW REPORT

Table of Content

1. ASIA-PACIFIC HORMONE REPLACEMENT THERAPY MARKET - SUMMARY

2. INDUSTRY OUTLOOK

2.1. IMPACT OF COVID-19 ON HORMONE REPLACEMENT THERAPY MARKET

2.2. KEY INSIGHTS

2.2.1. INTRODUCTION OF NEW DRUG DELIVERY SYSTEMS FOR HORMONE REPLACEMENT

2.2.2. MODERN SEDENTARY LIFESTYLES

2.3. PORTER’S FIVE FORCES MODEL

2.3.1. THREAT OF NEW ENTRANTS

2.3.2. THREAT OF SUBSTITUTE PRODUCTS

2.3.3. BARGAINING POWER OF BUYERS

2.3.4. BARGAINING POWER OF SUPPLIERS

2.3.5. COMPETITIVE RIVALRY

2.4. MARKET ATTRACTIVENESS INDEX

2.5. VENDOR SCORECARD

2.6. KEY STRATEGIC DEVELOPMENTS

2.6.1. ACQUISITIONS & MERGERS

2.6.2. PRODUCT LAUNCH & DEVELOPMENTS

2.6.3. CONTRACTS AND PARTNERSHIPS

2.6.4. BUSINESS EXPANSIONS, ANNOUNCEMENTS, & DIVESTITURES

2.7. MARKET DRIVERS

2.7.1. RISE IN AWARENESS PERTAINING TO HEALTH PROBLEMS DURING MENOPAUSE

2.7.2. INCREASE IN PREVALENCE OF HORMONAL DISORDERS

2.7.3. NEW PRODUCT LAUNCHES BY MAJOR GIANTS

2.8. MARKET RESTRAINTS

2.8.1. HIGH COST OF TREATMENT

2.8.2. ADVERSE REACTIONS ASSOCIATED WITH HORMONE REPLACEMENT THERAPY

2.9. MARKET OPPORTUNITIES

2.9.1. AVAILABILITY OF ALTERNATIVE THERAPY OFFERS OPPORTUNITIES FOR THE MARKET’S GROWTH

2.9.2. LAUNCH OF TELEMEDICINE CLINICAL PRACTICE SERVICES

3. ASIA-PACIFIC HORMONE REPLACEMENT THERAPY MARKET - BY THERAPY TYPE

3.1. ESTROGEN HORMONE REPLACEMENT THERAPY

3.2. THYROID HORMONE REPLACEMENT THERAPY

3.3. TESTOSTERONE HORMONE REPLACEMENT THERAPY

3.4. HUMAN GROWTH HORMONE REPLACEMENT THERAPY

3.5. PROGESTOGEN HORMONE REPLACEMENT THERAPY

4. ASIA-PACIFIC HORMONE REPLACEMENT THERAPY MARKET - BY TYPE OF DISEASE

4.1. MENOPAUSE

4.2. MALE HYPOGONADISM

4.3. GROWTH HORMONE DEFICIENCY

4.4. HYPOTHYROIDISM

4.5. OTHER TYPE OF DISEASES

5. ASIA-PACIFIC HORMONE REPLACEMENT THERAPY MARKET - BY ROUTE OF ADMINISTRATION

5.1. ORAL

5.2. PARENTERAL

5.3. TRANSDERMAL

5.4. OTHER ROUTES OF ADMINISTRATION

6. ASIA-PACIFIC HORMONE REPLACEMENT THERAPY MARKET – COUNTRY OUTLOOK

6.1. CHINA

6.2. JAPAN

6.3. INDIA

6.4. AUSTRALIA & NEW ZEALAND

6.5. SOUTH KOREA

6.6. ASEAN COUNTRIES

6.7. REST OF ASIA-PACIFIC

7. COMPETITIVE LANDSCAPE

7.1. ABBOTT LABORATORIES

7.2. AMGEN

7.3. ANI PHARMACEUTICALS

7.4. BAYER AG

7.5. DR REDDY’S LABORATORIES LTD

7.6. ELI LILLY & COMPANY

7.7. GENENTECH INC

7.8. IPSEN

7.9. MERCK KGAA

7.10. NOVARTIS AG

7.11. NOVEN PHARMACEUTICALS INC

7.12. NOVO NORDISK A/S

7.13. PFIZER INC

7.14. TEVA PHARMACEUTICAL INDUSTRIES LTD

7.15. VIATRIS INC (MYLAN NV)

8. RESEARCH METHODOLOGY & SCOPE

8.1. RESEARCH SCOPE & DELIVERABLES

8.1.1. OBJECTIVES OF STUDY

8.1.2. SCOPE OF STUDY

8.2. SOURCES OF DATA

8.2.1. PRIMARY DATA SOURCES

8.2.2. SECONDARY DATA SOURCES

8.3. RESEARCH METHODOLOGY

8.3.1. EVALUATION OF PROPOSED MARKET

8.3.2. IDENTIFICATION OF DATA SOURCES

8.3.3. ASSESSMENT OF MARKET DETERMINANTS

8.3.4. DATA COLLECTION

8.3.5. DATA VALIDATION & ANALYSIS

List of Tables

TABLE 1:       ASIA-PACIFIC HORMONE REPLACEMENT THERAPY MARKET, COUNTRY OUTLOOK, 2021-2028 (IN $ MILLION)

TABLE 2:       VENDOR SCORECARD

TABLE 3:       LIST OF ACQUISITIONS & MERGERS

TABLE 4:       LIST OF PRODUCT LAUNCHES & DEVELOPMENTS

TABLE 5:       LIST OF CONTRACTS AND PARTNERSHIPS

TABLE 6:       ASIA-PACIFIC HORMONE REPLACEMENT THERAPY MARKET, COUNTRY OUTLOOK, 2021-2028 (IN $ MILLION)

TABLE 7:       ASIA-PACIFIC HORMONE REPLACEMENT THERAPY MARKET, BY THERAPY TYPE, 2021-2028 (IN $ MILLION)

TABLE 8:       ASIA-PACIFIC HORMONE REPLACEMENT THERAPY MARKET, BY TYPE OF DISEASE, 2021-2028 (IN $ MILLION)

TABLE 9:       ASIA-PACIFIC HORMONE REPLACEMENT THERAPY MARKET, BY ROUTE OF ADMINISTRATION, 2021-2028 (IN $ MILLION)

List of Figures

FIGURE 1:     ASIA-PACIFIC HORMONE REPLACEMENT THERAPY MARKET 2021-2028 (IN $ MILLION)

FIGURE 2:     ASIA-PACIFIC HORMONE REPLACEMENT THERAPY MARKET, BY THERAPY TYPE, 2020 & 2028 (IN %)

FIGURE 3:     ASIA-PACIFIC HORMONE REPLACEMENT THERAPY MARKET, BY ESTROGEN HORMONE REPLACEMENT THERAPY, 2021-2028 (IN $ MILLION)

FIGURE 4:     ASIA-PACIFIC HORMONE REPLACEMENT THERAPY MARKET, BY THYROID HORMONE REPLACEMENT THERAPY, 2021-2028 (IN $ MILLION)

FIGURE 5:     ASIA-PACIFIC HORMONE REPLACEMENT THERAPY MARKET, BY TESTOSTERONE HORMONE REPLACEMENT THERAPY, 2021-2028 (IN $ MILLION)

FIGURE 6:     ASIA-PACIFIC HORMONE REPLACEMENT THERAPY MARKET, BY HUMAN GROWTH HORMONE REPLACEMENT THERAPY, 2021-2028 (IN $ MILLION)

FIGURE 7:     ASIA-PACIFIC HORMONE REPLACEMENT THERAPY MARKET, BY PROGESTOGEN HORMONE REPLACEMENT THERAPY, 2021-2028 (IN $ MILLION)

FIGURE 8:     ASIA-PACIFIC HORMONE REPLACEMENT THERAPY MARKET, BY TYPE OF DISEASE, 2020 & 2028 (IN %)

FIGURE 9:     ASIA-PACIFIC HORMONE REPLACEMENT THERAPY MARKET, BY MENOPAUSE, 2021-2028 (IN $ MILLION)

FIGURE 10:  ASIA-PACIFIC HORMONE REPLACEMENT THERAPY MARKET, BY MALE HYPOGONADISM, 2021-2028 (IN $ MILLION)

FIGURE 11:  ASIA-PACIFIC HORMONE REPLACEMENT THERAPY MARKET, BY GROWTH HORMONE DEFICIENCY, 2021-2028 (IN $ MILLION)

FIGURE 12:  ASIA-PACIFIC HORMONE REPLACEMENT THERAPY MARKET, BY HYPOTHYROIDISM, 2021-2028 (IN $ MILLION)

FIGURE 13:  ASIA-PACIFIC HORMONE REPLACEMENT THERAPY MARKET, BY OTHER TYPE OF DISEASES, 2021-2028 (IN $ MILLION)

FIGURE 14:  ASIA-PACIFIC HORMONE REPLACEMENT THERAPY MARKET, BY ROUTE OF ADMINISTRATION, 2020 & 2028 (IN %)

FIGURE 15:  ASIA-PACIFIC HORMONE REPLACEMENT THERAPY MARKET, BY ORAL, 2021-2028 (IN $ MILLION)

FIGURE 16:  ASIA-PACIFIC HORMONE REPLACEMENT THERAPY MARKET, BY PARENTERAL, 2021-2028 (IN $ MILLION)

FIGURE 17:  ASIA-PACIFIC HORMONE REPLACEMENT THERAPY MARKET, BY TRANSDERMAL, 2021-2028 (IN $ MILLION)

FIGURE 18:  ASIA-PACIFIC HORMONE REPLACEMENT THERAPY MARKET, BY OTHER ROUTES OF ADMINISTRATION, 2021-2028 (IN $ MILLION)

FIGURE 19:  CHINA HORMONE REPLACEMENT THERAPY MARKET 2021-2028 (IN $ MILLION)

FIGURE 20:  JAPAN HORMONE REPLACEMENT THERAPY MARKET 2021-2028 (IN $ MILLION)

FIGURE 21:  INDIA HORMONE REPLACEMENT THERAPY MARKET 2021-2028 (IN $ MILLION)

FIGURE 22:  AUSTRALIA & NEW ZEALAND HORMONE REPLACEMENT THERAPY MARKET 2021-2028 (IN $ MILLION)

FIGURE 23:  SOUTH KOREA HORMONE REPLACEMENT THERAPY MARKET 2021-2028 (IN $ MILLION)

FIGURE 24:  ASEAN COUNTRIES HORMONE REPLACEMENT THERAPY MARKET 2021-2028 (IN $ MILLION)

FIGURE 25:  REST OF ASIA-PACIFIC HORMONE REPLACEMENT THERAPY MARKET 2021-2028 (IN $ MILLION)

Purchase Options

  • Licence Type
  • Price
  • User/Sharing
  • Printing
  • Delivery Formats
  • Free customization (Pre-sale)
  • Analyst hour support (Post Sale)
  • Customized notification for newly published report
  • Free report on update (within 180 days)

Single User PDF

$1,500.00

  • User/Sharing
  • Restricted to one authorized user
  • Printing
  • Not printable
  • Delivery Formats
  • Pdf
  • Free customization (Pre-sale)
  • 10% Free customization
  • Analyst hour support (Post Sale)
  • 3 hours
  • Customized notification (newly published)
  • Free report on update (within 180 days)

Enterprise Online/PDF

$2,200.00

  • User/Sharing
  • Unlimited
  • Printing
  • Unlimited
  • Delivery Formats
  • Pdf and market estimation excel
  • Free customization (Pre-sale)
  • 20% Free customization
  • Analyst hour support (Post Sale)
  • 8 hour
  • Customized notification (newly published)
  • Free report on update (within 180 days)

Request free Sample

SUBMIT REQUEST
Request Custom Report

Request Custom Report

Enquire before buying

Enquire Before Buying

;